What Is to Be Done

Since its existence, the feminist movement has fought for equal rights for women, and, in so doing, it has challenged the oldest and most fundamental social scheme in history-patriarchy. Patriarchy is the rule of males over females in all departments of human life, and it is based on custom, belief, law, and ultimately on force. Although the American feminist movement made significant progress in its early years, it has struggled in recent years to accomplish many of its goals. Millett notes that the American feminist movement now stands stalemated, on the defensive, and trying desperately to hold on to the gains it has made. Millett argues that the American feminist movement still can bring about the last days of patriarchy by aligning itself with the international feminist movement. There, feminists have brought about great change by ratifying documents such as the Convention on the Elimination of All Forms of Discrimination Against Women. This document, which is still unratified by the United States, is set up with mechanisms that allow nations to bring about sexual equality. Because it challenges patriarchy generally and the American right wing in particular, Millett argues, the Convention has been kept forcibly out of public discussion in the United States. Paradoxically, its obscurity testifies to its power

Support for UNRWA's survival

The United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA) provides life-saving humanitarian aid for 5·4 million Palestine refugees now entering their eighth decade of statelessness and conflict. About a third of Palestine refugees still live in 58 recognised camps. UNRWA operates 702 schools and 144 health centres, some of which are affected by the ongoing humanitarian disasters in Syria and the Gaza Strip. It has dramatically reduced the prevalence of infectious diseases, mortality, and illiteracy. Its social services include rebuilding infrastructure and homes that have been destroyed by conflict and providing cash assistance and micro-finance loans for Palestinians whose rights are curtailed and who are denied the right of return to their homeland

Anderson's ethical vulnerability: animating feminist responses to sexual violence

Pamela Sue Anderson argues for an ethical vulnerability which “activates an openness to becoming changed” that “can make possible a relational accountability to one another on ethical matters”. In this essay I pursue Anderson’s solicitation that there is a positive politics to be developed from acknowledging and affirming vulnerability. I propose that this politics is one which has a specific relevance for animating the terms of feminist responses to sexual violence, something which has proved difficult for feminist theorists and activists alike. I will demonstrate the contribution of Anderson’s work to such questions by examining the way in which “ethical vulnerability” as a framework can illuminate the intersectional feminist character of Tarana Burke’s grassroots Me Too movement when compared with the mainstream, viral version of the movement. I conclude by arguing that Anderson’s “ethical vulnerability” contains ontological insights which can allay both activist and academic concerns regarding how to respond to sexual violence

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. METHODS: In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. FINDINGS: Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1·4%, 95% CI -7·0 to 4·3; hazard ratio 0·96, 0·68-1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3-4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). INTERPRETATION: Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. FUNDING: UK National Institute for Health Research Health Technology Assessment

What Is to Be Done

Since its existence, the feminist movement has fought for equal rights for women, and, in so doing, it has challenged the oldest and most fundamental social scheme in history-patriarchy. Patriarchy is the rule of males over females in all departments of human life, and it is based on custom, belief, law, and ultimately on force. Although the American feminist movement made significant progress in its early years, it has struggled in recent years to accomplish many of its goals. Millett notes that the American feminist movement now stands stalemated, on the defensive, and trying desperately to hold on to the gains it has made. Millett argues that the American feminist movement still can bring about the last days of patriarchy by aligning itself with the international feminist movement. There, feminists have brought about great change by ratifying documents such as the Convention on the Elimination of All Forms of Discrimination Against Women. This document, which is still unratified by the United States, is set up with mechanisms that allow nations to bring about sexual equality. Because it challenges patriarchy generally and the American right wing in particular, Millett argues, the Convention has been kept forcibly out of public discussion in the United States. Paradoxically, its obscurity testifies to its power

Out. Citation de Kate Millet : La prostitution, quatuor pour voix féminines, Ed. Denoël-Gonthier

Millett Kate. Out. Citation de Kate Millet : La prostitution, quatuor pour voix féminines, Ed. Denoël-Gonthier . In: Sorcières : les femmes vivent, n°3, 1976. Se prostituer. p. 42